MPO and multiple sclerosis: Studies in animal models of Multiple Sclerosis (EAE) [106], multiple system atrophy [107,108] and in an animal model of amyotrophic lateral sclerosis [109] indicate that blocking MPO activity lessens disease and improves motor behavior, pointing to the usefulness of developing MPO inhibitors.